To date, advances in our understanding of the association of allelic variants of ghrelin and its receptor with cancer have been directed primarily towards oesophageal cancer [36], colorectal cancer [37,38], breast cancer [39], and non-Hodgkin’s lymphoma [40]. Here, GHRL is linked to colorectal cancer.